Australian Research
Australia has been leading the way with SCN2A research, both in outlining the clinical features and developing precision based treatments.
Latest Posts
Natural history studies and clinical trial readiness for genetic developmental and epileptic encephalopathies
December 30, 2021
No Comments
Natural history studies are critical for clinical trial design & registration of new treatments for developmental epileptic encephalopathies.
ASO for SCN2A gain of function mutation in mice
December 6, 2021
No Comments
Gene-based therapy using ASO-mediated mRNA was very effective in a mouse model of SCN2A.
SCN2A International Natural History Study
July 18, 2021
No Comments
Help understand SCN2A by enrolling in this natural history study which is open to participants from any country.